Wan Q. Chong
1E Lower Kent Ridge Road
Singapore, 119228, Singapore
Singapore, 119228, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Stakeholder priorities for advancing integrative oncology across a pluralistic health system: a qualitative study from Singapore.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 08, 2026
A Multicentre Phase II Study of Trifluridine/Tipiracil in Recurrent/Metastatic Platinum-Resistant Nasopharyngeal Carcinomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 31, 2026
Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122.
Journal: Cancer medicine
Published: April 11, 2025
Is the abundance of B cells the best biomarker to predict immune checkpoint inhibitor response in head and neck squamous cell cancers?
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 03, 2025
Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 21, 2023
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 01, 2022
Systematic Review and Meta-Analysis of the Influence of Genetic Variation on Ototoxicity in Platinum-Based Chemotherapy.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: May 03, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors.
Journal: Targeted oncology
Published: April 26, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 30, 2021
Immunohistochemistry study of tumor vascular normalization and anti-angiogenic effects of sunitinib versus bevacizumab prior to dose-dense doxorubicin/cyclophosphamide chemotherapy in HER2-negative breast cancer.
Journal: Breast cancer research and treatment
Published: August 16, 2021
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefit.
Journal: Cancer immunology, immunotherapy : CII
Published: June 12, 2021
Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy.
Journal: Journal of health psychology
Published: February 08, 2021
Last Updated: 09/26/2026